— Know what they know.
Not Investment Advice

Financial News

Sentiment -27.5 4843 articles 2374 bullish 1252 bearish Full Index →
SK Hynix Targets Massive US IPO To Fuel Global AI Chip Expan

SK Hynix Targets Massive US IPO To Fuel Global AI Chip Expansion

SK Hynix is pursuing a major capital raise and expanding production amid intensifying competition in the AI chip market. U.S. IPO Plans To Fund...
📰

NANOBIOTIX Statement Regarding Recent Media Speculation

PARIS and CAMBRIDGE, Mass., March 25, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering...
📰

Declaration de NANOBIOTIX concernant une recente rumeur mediatique

PARIS, FRANCE; CAMBRIDGE, Massachusetts, 25 mars 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société »), société...
📰

NANOBIOTIX Statement Regarding Recent Media Speculation

PARIS and CAMBRIDGE, Mass., March 25, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage...
Rezolute Stock Gains After FDA Meeting on Ersodetug Program

Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update

RZLT stock jumps 12% after an FDA meeting highlights ersodetug data and next steps, despite an earlier phase III setback in the congenital HI study.
Rezolute Stock Gains After FDA Meeting on Ersodetug Program

Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update

RZLT stock jumps 12% after an FDA meeting highlights ersodetug data and next steps, despite an earlier phase III setback in the congenital HI study.
Rezolute Stock Gains After FDA Meeting on Ersodetug Program

Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update

RZLT stock jumps 12% after an FDA meeting highlights ersodetug data and next steps, despite an earlier phase III setback in the congenital HI study.
Rezolute Stock Gains After FDA Meeting on Ersodetug Program

Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update

RZLT stock jumps 12% after an FDA meeting highlights ersodetug data and next steps, despite an earlier phase III setback in the congenital HI study.
Circle Stock Is Volatile - Here's Why

Circle Stock Is Volatile - Here's Why

Circle Internet Group Inc (NYSE:CRCL) stock tumbled on Tuesday after a restrictive Senate draft of a stablecoin bill rattled investors. However,...
📰

If You Invested $100 In BeOne Medicines Stock 10 Years Ago, You Would Have This Much Today

BeOne Medicines (NASDAQ:ONC) has outperformed the market over the past 10 years by 13.53% on an annualized basis producing an average annual return...
TendedBar Enters Production on New Countertop Unit and Selec

TendedBar Enters Production on New Countertop Unit and Selects Slabb Kiosks as Long-Term Manufacturing Partner

JACKSONVILLE, Fla., March 25, 2026 /PRNewswire/ -- TendedBar, a provider of automated beverage dispensing systems for high-traffic hospitality...
📰

Collegium Pharmaceutical EVP Sells Nearly 50,000 Shares Worth $2 Million

Collegium Pharmaceutical, a leader in abuse-deterrent pain therapies, saw its Chief Commercial Officer trim his stake by more than 40%.
Wall Street Analysts Believe Star Equity Holdings (STRR) Cou

Wall Street Analysts Believe Star Equity Holdings (STRR) Could Rally 92.31%: Here's is How to Trade

The consensus price target hints at a 92.3% upside potential for Star Equity Holdings (STRR). While empirical research shows that this sought-after...
📰

Why DexCom (DXCM) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
MDT Expands Agreement With Merit to Offer ViaVerte: Stock to

MDT Expands Agreement With Merit to Offer ViaVerte: Stock to Gain?

Medtronic expands its pain portfolio with a new ViaVerte BVNA system deal with Merit, aiming to tap rising demand for minimally invasive chronic pain...
MDT Expands Agreement With Merit to Offer ViaVerte: Stock to

MDT Expands Agreement With Merit to Offer ViaVerte: Stock to Gain?

Medtronic expands its pain portfolio with a new ViaVerte BVNA system deal with Merit, aiming to tap rising demand for minimally invasive chronic pain...
MDT Expands Agreement With Merit to Offer ViaVerte: Stock to

MDT Expands Agreement With Merit to Offer ViaVerte: Stock to Gain?

Medtronic expands its pain portfolio with a new ViaVerte BVNA system deal with Merit, aiming to tap rising demand for minimally invasive chronic pain...
MDT Expands Agreement With Merit to Offer ViaVerte: Stock to

MDT Expands Agreement With Merit to Offer ViaVerte: Stock to Gain?

Medtronic expands its pain portfolio with a new ViaVerte BVNA system deal with Merit, aiming to tap rising demand for minimally invasive chronic pain...
📰

Here's Why Royal Philips (PHG) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks...
📰

Here's Why The Cooper Companies (COO) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
📰

Is Astellas Pharma (ALPMY) Outperforming Other Medical Stocks This Year?

Here is how Astellas Pharma Inc. (ALPMY) and Cardinal Health (CAH) have performed compared to their sector so far this year.
📰

Is Astellas Pharma (ALPMY) Outperforming Other Medical Stocks This Year?

Here is how Astellas Pharma Inc. (ALPMY) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Is Novo Nordisk's Experimental Obesity Drug Outperforming Se

Is Novo Nordisk's Experimental Obesity Drug Outperforming Semaglutide?

The United Laboratories International Holdings Limited and Novo Nordisk A/S (NYSE:NVO) reported Wednesday topline data from a phase 2 trial in China...
Is Novo Nordisk's Experimental Obesity Drug Outperforming Se

Is Novo Nordisk's Experimental Obesity Drug Outperforming Semaglutide?

The United Laboratories International Holdings Limited and Novo Nordisk A/S (NYSE:NVO) reported Wednesday topline data from a phase 2 trial in China...
📰

Sarepta Therapeutics (SRPT) at a Crossroads: A 2026 Deep Dive into the Future of Genetic Medicine - FinancialContent

Sarepta Therapeutics (SRPT) at a Crossroads: A 2026 Deep Dive into the Future of Genetic Medicine  FinancialContent
Down 12.9% in 4 Weeks, Here's Why You Should You Buy the Dip

Down 12.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Indivior Pharmaceuticals Inc. (INDV)

The heavy selling pressure might have exhausted for Indivior Pharmaceuticals Inc. (INDV) as it is technically in oversold territory now. In addition...
Down 27% in 4 Weeks, Here's Why Adma Biologics (ADMA) Looks

Down 27% in 4 Weeks, Here's Why Adma Biologics (ADMA) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Adma Biologics (ADMA) as it is technically in oversold territory now. In addition to this...
📰

BSX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>SAN...
Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Go

Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It?

According to the average brokerage recommendation (ABR), one should invest in Intuitive Surgical (ISRG). It is debatable whether this highly...
Architect Financial Technologies Partners with MarketVector

Architect Financial Technologies Partners with MarketVector Indexes to Launch Interest Rate Perpetual Futures on AX

Partnership introduces the financial industry's first exchange-traded perpetual futures on interest rate benchmarks CHICAGO, March 25, 2026...
📰

Green Rain Energy Holdings (OTCID: GREH) Announces Enhanced Dividend Structure and Operational Milestones

ROCHESTER, N.Y., March 25, 2026 (GLOBE NEWSWIRE) -- Green Rain Energy Holdings Inc. (OTC:GREH) ("Green Rain" or the "Company") today announced that...
📰

Are Options Traders Betting on a Big Move in CONMED Stock?

Investors need to pay close attention to CNMD stock based on the movements in the options market lately.
Why Are Alibaba Shares Surging On Wednesday?

Why Are Alibaba Shares Surging On Wednesday?

Alibaba Group Holding Ltd (NYSE:BABA) shares jumped Wednesday following reports that China's intense food-delivery price wars are concluding....
📰

Nasus Pharma Ltd. reports FY results

Microsoft, Nvidia Team Up To Build AI-Powered Nuclear Energy

Microsoft, Nvidia Team Up To Build AI-Powered Nuclear Energy Future

Microsoft Corp (NASDAQ:MSFT) is expanding its AI ambitions through a new partnership with Nvidia Corp (NASDAQ:NVDA) while analysts remain bullish on...
📰

Gear Up for Phreesia (PHR) Q4 Earnings: Wall Street Estimates for Key Metrics

Beyond analysts' top-and-bottom-line estimates for Phreesia (PHR), evaluate projections for some of its key metrics to gain a better insight into how...
📰

SRx Health Solutions Hedges Decentralized Finance (DeFi) Portfolio with Investment in Gold and Reduces its Emerging Market Hedge

NORTH PALM BEACH, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies...
Unlocking Value: The Data-Driven Case for Scalable Gold Asse

Unlocking Value: The Data-Driven Case for Scalable Gold Assets

Issued on behalf of Lake Victoria Gold Ltd. USANewsGroup.com News Commentary VANCOUVER, BC, March 25, 2026 /PRNewswire/ -- Global gold demand...
📰

SRx Health Solutions Hedges Decentralized Finance (DeFi) Portfolio with Investment in Gold and Reduces its Emerging Market Hedge

NORTH PALM BEACH, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") and EMJ Crypto...
📰

Absci (ABSI) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.Tuesday, March 24, 2026 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
📰

Denali gains on FDA approval of lead asset

📰

Denali gains on FDA approval of lead asset

Amazon Gets In Tesla's Turf, Acquires Fauna Robotics To Put

Amazon Gets In Tesla's Turf, Acquires Fauna Robotics To Put 'Sprout' Humanoid In Your Living Room

Amazon.com Inc (NASDAQ:AMZN) is accelerating its push into consumer robotics as it looks to expand beyond logistics and unlock new growth...
« Prev 1 20 21 22 23 24 79 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms